The originator is hedging through co-marketing deals with Emcure (Wegovy under the Poviztra brand) and Abbott India (Ozempic under Extensior)
VX-150 induces analgesia without compromising subject safety in a phase 1 study
How to avoid 'Ozempic Face' To minimize the appearance of 'Ozempic Face,' consider maintaining a balanced, high-protein diet to support skin health and elasticity
Common side effects include gastrointestinal symptoms (such as nausea, vomiting, or diarrhea), which tend to improve over time
A typical semaglutide titration protocol might progress: Weeks 1-4: 0.25 mg weekly subcutaneous injection Weeks 5-8: 0.5 mg weekly injection Weeks 9-12: 1.0 mg weekly injection Weeks 13-16: 1.7 mg weekly injection (if tolerated and clinically appropriate) Weeks 17+: 2.4 mg weekly maintenance dose (if tolerated and needed for ongoing weight loss) This gradual escalation allows the gastrointestinal system to adapt to medication effects, reduces severity of common side effects like nausea and vomiting, and enables providers to identify appropriate maintenance doses balancing effectiveness against tolerability for each individual patient
Osteoarthritis (OA) is a condition where the protective cartilage covering the ends of bones gradually wears down
@lowres.png)
